Premier Alternatives

Stratus Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases. Stratus Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $210 million in Jan 2023. It has raised $184 million.

Last reported valuation
$210.0M
Oct 2026
Priced at
—
Total raised
$184.1M
Last round
—

Stratus Therapeutics key facts

as of Oct 2026
  • Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases.
  • Stratus Therapeutics is valued at approximately $210.0M as of Oct 2026 (last reported valuation).
  • It has raised $184.1M; the latest was Early Stage VC ($50.0M) in Mar 2025.
  • Notable investors include Alexandria Venture Investments, OrbiMed, Cormorant Asset Management, Monashee Investment Management, Ridgeback Capital — 13 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$210.0M

Stratus Therapeutics's last reported valuation, Jan 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Stratus Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Stratus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Stratus Therapeutics funding rounds

No rounds on record

No funding rounds for Stratus Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Stratus Therapeutics valuation

Stratus Therapeutics's last reported valuation was $210 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

Stratus Therapeutics investors

13 investors are on record for Stratus Therapeutics, including Alexandria Venture Investments, OrbiMed, Cormorant Asset Management and Monashee Investment Management. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 growth equity firm.

About Stratus Therapeutics

Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases. The company provides expertise in using zebrafish, mice, and human-induced pluripotent stem cells to clone and analyze novel genes and mechanisms important for blood formation, enabling patients to receive mechanism-based therapies.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2021
Employees
61
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.